about
Molecular Aspects of Head and Neck Cancer TherapyDifferential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neckComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsAltered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients.Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurementUnraveling the molecular genetics of head and neck cancer through genome-wide approachesMammalian target of rapamycin and head and neck squamous cell carcinomaInverse relationship between p53 and phospho-Chk1 (Ser317) protein expression in UVB-induced skin tumors in SKH-1 miceDisruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.A non-random deletion in the p53 gene in oral squamous cell carcinoma.Head and Neck Squamous Cell Cancer: Biology (II) and Translational Methods.Serum Survivin and TP53 Gene Expression in Children with Acute Lymphoblastic Leukemia.Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neckMolecular techniques and genetic alterations in head and neck cancer.Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.p53-based therapeutics for head and neck squamous cell carcinomaOncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinomaInhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G₂ delay and mitotic defects.Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neckp53 Overexpression in laryngeal squamous cell carcinoma and dysplasia.The p53 status of cultured human premalignant oral keratinocytes.C-deletion in exon 4 codon 63 of p53 gene as a molecular marker for oral squamous cell carcinoma: A preliminary study.p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neckComparison of p53 gene mutation and protein overexpression in colorectal carcinomasPITX1 is a novel predictor of the response to chemotherapy in head and neck squamous cell carcinoma.Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study.High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection.The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma
P2860
Q4649310-426A13E8-27CA-4C0C-A4AE-AEFD6A655CEEQ54832949-1AE51B05-CF01-4F8B-9628-A7C740FC6E97Q54832960-AF99863B-0317-4F08-8BA3-41A55B8B10A3Q54832961-48D2AA45-9224-45D4-AA1A-4D2ADE412F23Q54833221-6EC8B807-0505-4887-911B-A9856F501D86Q54952338-CF49B3BB-DC68-4FF1-88E4-544F375DB865Q54952341-E0D4A42C-55B8-4805-ACA1-0B719903189DQ54952345-D2E69F40-CF35-4DF0-BCCF-5FECDB482851Q54953470-A65B8AEA-D1B0-4D5C-BD2B-696E8772A8AFQ54990802-573DFE38-04A8-4E68-8F17-EE436936895DQ54990803-DC7C5076-AD7B-4901-A362-36AC69FAB281Q54990825-9E8D3E67-2677-4038-AA20-1A6BA4C60E70Q54990831-86722D72-3B5F-429D-B866-559CF597B6E6Q54990839-70524B9E-96E3-45E4-B205-CA8829820DF1Q54990896-B3F66942-82B3-4D37-95EE-EE29B3E867E6
P1343
Q28082815-3C47948C-0EC7-4693-BCB5-1BDAC43276E7Q28346765-744139AD-043F-410B-94BC-EA1F228C9A45Q28485279-A8BA6130-E04F-4FBF-8AFF-73479E4E9073Q33838868-60A37E12-1BC6-4033-9EB3-13E8FF940F44Q34537702-69CFFE82-19F9-47D8-8544-7C82D45DA8F2Q34961006-2ECC4B96-3B0A-4FB5-8D47-EDCD7733C143Q35025009-499BD1F6-17B3-41F2-9570-DA3AFA9EF146Q35027222-B8AEC34C-27F9-40D4-BE21-A7E2B0CA792BQ35195137-9DAD587A-380F-48B1-BC52-D8EDF7EB951EQ35510945-3EBB38E6-7E50-48E3-A8A8-83AC11583861Q35710194-D619C533-67B2-4896-8585-3584707669F8Q35984539-065428E0-4E72-4146-86CB-10CBC9FBF084Q36135100-3891B361-265F-4AEE-97FA-85A5C3943315Q36260727-1E2484F6-77D3-49E4-A929-F1430BAD6807Q36348778-489C00DE-6866-4D9D-BB35-3769463FF9B8Q37040328-262FF380-B53C-40AB-A0CE-C707C7D0CF42Q37233399-1C89C890-C3BB-4366-AD41-AB3E2636452EQ37385223-93F52191-5130-4EE7-9027-3A6392291505Q38102472-E0094D9C-83CA-4A71-8239-0FB53D023086Q38885144-B122386F-4F01-4350-BEB5-3761F2D4A8CFQ39096970-E450C028-CFB7-4385-9B69-D7DBF2DBCFDAQ39466612-FFD223BB-1357-4889-BEA2-BD499F78AA5EQ39598798-F5548EC2-637D-4BA3-BE84-7B42E2D81038Q40848876-F9382714-F9DE-4310-9CB3-8156B082A05FQ41438743-8F3A317D-3515-4B4D-8BE4-D68A49C88B33Q42116685-D291E64B-F65F-4F01-BC10-96FD3BBC9167Q42186316-A40092DB-AE2F-4174-90E9-B9D536135CA7Q42281113-EEF96145-DDC2-4BFB-880C-834B916FB5C4Q42576798-32D4A54B-74F6-46EA-8C24-7A1687CDD5DFQ42859206-B5958C31-DDA3-419B-B2E1-6F4362CFE2B4Q55037712-BB8392FC-D024-4D2E-8212-EAD3501915C3Q58068890-C497E0AF-AF89-47CA-AF3A-03667EEDDB40
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Frequent p53 mutations in head and neck cancer.
@en
Frequent p53 mutations in head and neck cancer.
@nl
type
label
Frequent p53 mutations in head and neck cancer.
@en
Frequent p53 mutations in head and neck cancer.
@nl
prefLabel
Frequent p53 mutations in head and neck cancer.
@en
Frequent p53 mutations in head and neck cancer.
@nl
P2093
P4510
P1433
P1476
Frequent p53 mutations in head and neck cancer.
@en
P2093
P304
P407
P577
1992-11-01T00:00:00Z